Mariette Labots

10PUBLICATIONS
88CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 13, 2026
Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?

|Apr 10, 2026
Tumor Whole-Genome Sequencing for Prediction of Venous Thromboembolism in Patients With Metastasized Solid Cancer.

Frits I Mulder, Noori A M Guman, Job van Riet

|Feb 19, 2026
Immune checkpoint inhibitor myocarditis: when profound troponin elevation diverges from unremarkable imaging.

Roel S Driessen, P Stefan Biesbroek, Philippe J van Rosendael

|Nov 10, 2025
Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal Cancer.

Sophie L Gerritse, Erik J van Helden, Anne I J Arens

|Oct 30, 2025
Acceptance in Patients With Cancer: A Scoping Review.

Joost Dekker, Chris Welling, Mariette Labots

|Oct 16, 2025
Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocol.

Ilse A C Spiekman, Niven Mehra, Laurien J Zeverijn

Pageof 2

Frequent Collaborators

4 joint publications

Henk Mw Verheul

3 joint publications

Emile E Voest

2 joint publications

Tineke E Buffart

2 joint publications

Louisa R Hoes